Found 8 matching trials
Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer
PHASE1This study will test how well a new combination of three drugs (Letrozole, ...
Location
University of Alabama at Birmingham
RAD001 Plus Carboplatin in Breast Cancer Patients
PHASE2This study investigates the effectiveness of combination of carboplatin and...
Location
NYU Clinical Cancer Center
Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI
PHASE2Post-menopausal women with hormone-receptor positive (HR+) metastatic breas...
Location
Marin Cancer Care
Comparison of Safety and Efficacy of de Novo Everolimus
NANowadays, de novo everolimus regimen in renal transplant patients is consid...
Comparison of Single-Agent Carboplatin vs the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple-Negative Breast Cancer
PHASE2The purpose of this study is to evaluate the safety and effectiveness of ca...
Location
Mount Sinai Downtown
Phase II Study of RAD001 Head and Neck Cancer
PHASE2To carry out exploratory studies to determine if activity of this regimen c...
Location
Hillman Cancer Center
RAD001 in Advanced Hepatocellular Carcinoma
PHASE1Laboratory studies have shown that RAD001 can prevent cells from multiplyin...
Location
Massachusetts General Hospital
RESTOR: PK/PD mTORi Inhibition in Older Adults
EARLY_PHASE1As people get older, there are changes in their cells and tissues that may ...
Location
The University of Texas Health Science Center at San Antonio